期刊文献+

糖肾清对DN模型大鼠肾组织形态学的影响 被引量:3

Morphologic Effect of Tangshenqing on Kidney of Rats with Diabetic Nephropathy
原文传递
导出
摘要 目的:探讨糖肾清对糖尿病大鼠肾脏形态学的影响。方法:将SD大鼠随机分为对照组、模型组、阳性药卡托普利(14 mg.kg-1)组、糖肾清高、中、低剂量(187,93.5,46.75 mg.kg-1)组,用STZ诱导大鼠糖尿病肾病(DN)模型,连续ig 12周后处死大鼠,取肾脏行HE,PAS染色,光镜下对肾组织病变进行分类评分,PAS染色下测定肾小球系膜基质相对面积。结果:糖肾清高剂量组的肾脏病变较模型组有所减轻,其肾小球基质相对面积较模型组明显减少(P<0.05)。结论:糖肾清能减轻DN大鼠肾小球细胞外基质的增生程度,对其肾脏病变具有保护作用。 Objective:To investigate morphologic effect of Tangshenqing on kidney of rats with diabetic nephropathy.Method:SD rats were induced diabetic nephropathy by STZ then randomly divided into normal control group,the model group,the positive group,the high dose of Tangshenqing group,the medium dose of Tangshenqing group and the low dose of the group.They were 187,93.5 and 46.75 mg·kg-1 respectively.After twelve weeks' oral drug administration,the rats were killed and the kidneys were harvested for hematoxylin and eosin and the periodic acid-sliver dyeing.The renal lesions were classified and scored under light microscope.The relative area of mesangium matrix was measured under the periodic acid-sliver dyeing.Result:The renal lesions of the high dose of Tangshenqing group was lightened than the model group.Mesangium matrix relative area of the high dose of Tangshenqing was obviously reduced than the model group(P0.05).Conclusion:Tangshenqing may relive the extent of mesangium matrix hyperplasia for rats with diabetic nephropathy.
出处 《中国实验方剂学杂志》 CAS 北大核心 2011年第14期156-159,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家自然科学基金项目(30772762)
关键词 糖肾清 糖尿病肾病 形态学 Tangshenqing diabetic nephropathy morphology
  • 相关文献

参考文献4

二级参考文献51

  • 1吕仁和,高彦彬,易京红,胡继玲,王越,冯兴忠,赵进喜,于秀辰,孙军,娄锡恩,杨晓晖,章鸿英,林得玉,范冠杰.止消通脉饮治疗糖尿病微血管病变的临床研究[J].北京中医药大学学报,1996,19(5):25-28. 被引量:20
  • 2时振生.时氏中医肾脏病学[M].北京:中国医药科技出版社,1997.292.
  • 3Iwamo M, Knbo A,Nishino T, et al.Kidn Int,1996;49:1120- 1126.
  • 4Hoffman BB, Sharma K,Zhu Yanqing, et al. Kidney Int, 1998;54(4):1107 - 1116.
  • 5Wolf G, Ziyadeh FN. Kidney Int, 1999;56(2) :393 - 405.
  • 6Sharma K,Ziyadeh FN, Diabetes, 1995;44(10): 1139 - 1146.
  • 7Koppinen E,et al. Diabetes Care,2000;23(5) :664.
  • 8Boner WA, Noble NA. Kidney Int, 1998; 54:1390 - 1391.
  • 9Rises- BL, Ladson-Wofford S, Sharba A,et al. Kidney Int, 1999;56(2):428 - 439.
  • 10Hong SW, Isono M,Chen S, et al. Am J Pathol,2001; 158(5) : 1653 -1663.

共引文献8

同被引文献49

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部